IP Library › Patent Application 18777075
Patent Application Utility Small
App. No. 18/777,075 · Confirmation No. 1865

USE OF SEMAPHORIN-4D ANTIBODIES IN COMBINATION WITH AN IMMUNE MODULATING THERAPY TO INHIBIT TUMOR GROWTH AND METASTASIS

Applicant: Vaccinex, Inc.
Docketed New Case - Ready for Examination View Publication ↗
⬇ PDF
 Code Description Pages PDF
2025-01-30 NTC.PUB Notice of Publication 1 View
2024-11-07 IDS Information Disclosure Statement (IDS) Form (SB08) 8 View
2024-11-07 TRAN.LET Transmittal Letter 2 View
2024-11-07 IDS Information Disclosure Statement (IDS) Form (SB08) 15 View
2024-11-07 IDS Information Disclosure Statement (IDS) Form (SB08) 7 View
2024-11-07 IDS Information Disclosure Statement (IDS) Form (SB08) 9 View
2024-11-07 IDS Information Disclosure Statement (IDS) Form (SB08) 8 View
2024-11-07 N417 Electronic Filing System Acknowledgment Receipt 3 View
2024-11-07 IDS Information Disclosure Statement (IDS) Form (SB08) 4 View
2024-10-25 APP.FILE.REC Filing Receipt 4 View
2024-10-25 WFEE Fee Worksheet (SB06) 1 View
2024-10-21 CRFE Sequence Listing in Computer Readable Format, No errors found — View
2024-10-21 CRFE Sequence Listing in Computer Readable Format, No errors found 13 View
2024-10-18 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-10-18 SPEC Specification 79 View
2024-10-18 REM Applicant Arguments/Remarks Made in an Amendment 79 View
2024-10-18 N417.PYMT Electronic Fee Payment 2 View
2024-10-18 PEFR Applicant Response to Pre-Exam Formalities Notice 1 View
2024-10-18 SPEC Specification 1 View
2024-10-18 REM Applicant Arguments/Remarks Made in an Amendment 1 View
2024-10-18 SEQ.XML Sequence Listing (XML File) 1 View
2024-10-10 WFEE Fee Worksheet (SB06) 1 View
2024-10-10 NT.INC.REPLY Notice of Incomplete Reply 4 View
2024-10-07 CRFD Sequence Listing in Computer Readable Format is Defective — View
2024-10-07 CRFD Sequence Listing in Computer Readable Format is Defective 13 View
2024-10-04 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-10-04 SPEC Specification 79 View
2024-10-04 REM Applicant Arguments/Remarks Made in an Amendment 79 View
2024-10-04 SEQ.XML Sequence Listing (XML File) 1 View
2024-08-05 APP.FILE.REC Filing Receipt 4 View
2024-08-05 WFEE Fee Worksheet (SB06) 1 View
2024-08-05 SEQ.REQ.DISC Requirements for Sequence Disclosure Notice 4 View
2024-08-05 WELCOME.LET Welcome Letter from USPTO Director and Deputy Director 1 View
2024-08-01 CRFD Sequence Listing in Computer Readable Format is Defective — View
2024-08-01 CRFD Sequence Listing in Computer Readable Format is Defective 19 View
2024-07-18 DRW.SUPP Drawings-black and white line and/or other drawings — View
2024-07-18 APP.TEXT Application body structured text document — View
2024-07-18 N417 Electronic Filing System Acknowledgment Receipt 3 View
2024-07-18 OATH Oath or Declaration filed 3 View
2024-07-18 N417.PYMT Electronic Fee Payment 2 View
2024-07-18 ADS Application Data Sheet 10 View
2024-07-18 SPEC Specification 79 View
2024-07-18 CLM Claims 3 View
2024-07-18 ABST Abstract 1 View
2024-07-18 DRW.NONBW Drawings-other than black and white line drawings 43 View
2024-07-18 PA.. Power of Attorney 2 View
2024-07-18 DRW.SUPP Drawings-black and white line and/or other drawings — View
2024-07-18 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
2024-07-18 SEQ.TXT Sequence Listing (Text File) 1 View
2024-07-18 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
18/777,075
Filed
2024-07-18
Pub. No.
US20250032609A1
Art Unit
OPAP